Please login to the form below

Not currently logged in
Email:
Password:

Study suggests SSRI risk for older people

Cohort study suggests new generation antidepressants, SSRIs, may carry greater risks than alternatives for older people

A study has suggested that the new generation of antidepressants, selective serotonin reuptake inhibitors (SSRIs), may have an increased risk for older people.

The study, published in the British Medical Journal (BMJ). indicated that SSRIs are associated with increased levels of several severe adverse outcomes in older people compared to alternative antidepressants such as tricyclics (TCAs).

The cohort investigation, conducted by the University of Nottingham and East Anglia, researched the association between antidepressant treatment and potential life threatening outcomes in patients aged 65 and over.

Overall it was found that SSRIs were associated with an increased risk of all cause mortality, stroke, falls, fracture, epilepsy or seizures and hyponatraemia.

Individual drugs such as trazodone (marketed as Desyrel by Bristol-Myers Squibb), mirtazapine (marketed as Remeron by Organon Pharmaceuticals) and venlafaxine (marketed as Effexor by Pfizer) were associated with the highest risks for several negative outcomes.

Although further research is needed to confirm these findings, the authors state that the risks and benefits of different antidepressants should be carefully evaluated when they are prescribed to older patients.

3rd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...

Infographics